The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer

Melanie Ongchin, Elizabeth Sharratt, Ivan Dominguez, Neka Simms, Jing Wang, Richard Cheney, Charles LeVea, Michael Brattain, Ashwani Rajput

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Colorectal cancer is the second leading cause of cancer related mortality, with a majority of deaths resulting from metastases. Few in vivo models allow for the study of the complex process of metastasis. The purpose of this study was to determine the effects of epidermal growth factor receptor activation and TGFβ pathway attenuation in FET, a weakly tumorigenic human colon cancer cell line, in an orthotopic model. Methods and Results: Using FET, FETα, FETαDNRII, and FETDNRII cells were constructed. Tumors were orthotopically implanted onto the colons of BALB/c nude mice. After 7 wk, the mice were euthanized and organs extracted for examination. All cell lines demonstrated primary invasion. FETα was weakly metastatic compared with FETαDNRII and FETDNRII, which demonstrated metastases to the lung and liver, respectively. Conclusion: Epidermal growth factor receptor (EGFR) activation transforms a nontumorigenic cell line into a tumorigenic but not metastatic one. The tumorigenic line becomes metastatic with the attenuation of TGFβ signaling. Loss of EGFR activation in the TGFβ inhibited line results in a decreased metastatic burden, but importantly, changes the organotropic homing from lung to liver. Thus, these in vivo studies demonstrate that EGFR activation and TGFβ signaling pathways play a role in tumorigenicity and in pattern of metastases.

Original languageEnglish (US)
Pages (from-to)250-256
Number of pages7
JournalJournal of Surgical Research
Volume156
Issue number2
DOIs
StatePublished - Oct 1 2009

Fingerprint

Epidermal Growth Factor Receptor
Colonic Neoplasms
Neoplasm Metastasis
Cell Line
Lung
Liver
Nude Mice
Colorectal Neoplasms
Neoplasms
Colon
Mortality

Keywords

  • Epidermal growth factor receptor
  • colon cancer
  • orthotopic model
  • transforming growth factor-β

ASJC Scopus subject areas

  • Surgery

Cite this

The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer. / Ongchin, Melanie; Sharratt, Elizabeth; Dominguez, Ivan; Simms, Neka; Wang, Jing; Cheney, Richard; LeVea, Charles; Brattain, Michael; Rajput, Ashwani.

In: Journal of Surgical Research, Vol. 156, No. 2, 01.10.2009, p. 250-256.

Research output: Contribution to journalArticle

Ongchin, M, Sharratt, E, Dominguez, I, Simms, N, Wang, J, Cheney, R, LeVea, C, Brattain, M & Rajput, A 2009, 'The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer', Journal of Surgical Research, vol. 156, no. 2, pp. 250-256. https://doi.org/10.1016/j.jss.2009.02.002
Ongchin, Melanie ; Sharratt, Elizabeth ; Dominguez, Ivan ; Simms, Neka ; Wang, Jing ; Cheney, Richard ; LeVea, Charles ; Brattain, Michael ; Rajput, Ashwani. / The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer. In: Journal of Surgical Research. 2009 ; Vol. 156, No. 2. pp. 250-256.
@article{3f858dfdbc2f4582a9e978a459fc38bc,
title = "The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer",
abstract = "Background: Colorectal cancer is the second leading cause of cancer related mortality, with a majority of deaths resulting from metastases. Few in vivo models allow for the study of the complex process of metastasis. The purpose of this study was to determine the effects of epidermal growth factor receptor activation and TGFβ pathway attenuation in FET, a weakly tumorigenic human colon cancer cell line, in an orthotopic model. Methods and Results: Using FET, FETα, FETαDNRII, and FETDNRII cells were constructed. Tumors were orthotopically implanted onto the colons of BALB/c nude mice. After 7 wk, the mice were euthanized and organs extracted for examination. All cell lines demonstrated primary invasion. FETα was weakly metastatic compared with FETαDNRII and FETDNRII, which demonstrated metastases to the lung and liver, respectively. Conclusion: Epidermal growth factor receptor (EGFR) activation transforms a nontumorigenic cell line into a tumorigenic but not metastatic one. The tumorigenic line becomes metastatic with the attenuation of TGFβ signaling. Loss of EGFR activation in the TGFβ inhibited line results in a decreased metastatic burden, but importantly, changes the organotropic homing from lung to liver. Thus, these in vivo studies demonstrate that EGFR activation and TGFβ signaling pathways play a role in tumorigenicity and in pattern of metastases.",
keywords = "Epidermal growth factor receptor, colon cancer, orthotopic model, transforming growth factor-β",
author = "Melanie Ongchin and Elizabeth Sharratt and Ivan Dominguez and Neka Simms and Jing Wang and Richard Cheney and Charles LeVea and Michael Brattain and Ashwani Rajput",
year = "2009",
month = "10",
day = "1",
doi = "10.1016/j.jss.2009.02.002",
language = "English (US)",
volume = "156",
pages = "250--256",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer

AU - Ongchin, Melanie

AU - Sharratt, Elizabeth

AU - Dominguez, Ivan

AU - Simms, Neka

AU - Wang, Jing

AU - Cheney, Richard

AU - LeVea, Charles

AU - Brattain, Michael

AU - Rajput, Ashwani

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Background: Colorectal cancer is the second leading cause of cancer related mortality, with a majority of deaths resulting from metastases. Few in vivo models allow for the study of the complex process of metastasis. The purpose of this study was to determine the effects of epidermal growth factor receptor activation and TGFβ pathway attenuation in FET, a weakly tumorigenic human colon cancer cell line, in an orthotopic model. Methods and Results: Using FET, FETα, FETαDNRII, and FETDNRII cells were constructed. Tumors were orthotopically implanted onto the colons of BALB/c nude mice. After 7 wk, the mice were euthanized and organs extracted for examination. All cell lines demonstrated primary invasion. FETα was weakly metastatic compared with FETαDNRII and FETDNRII, which demonstrated metastases to the lung and liver, respectively. Conclusion: Epidermal growth factor receptor (EGFR) activation transforms a nontumorigenic cell line into a tumorigenic but not metastatic one. The tumorigenic line becomes metastatic with the attenuation of TGFβ signaling. Loss of EGFR activation in the TGFβ inhibited line results in a decreased metastatic burden, but importantly, changes the organotropic homing from lung to liver. Thus, these in vivo studies demonstrate that EGFR activation and TGFβ signaling pathways play a role in tumorigenicity and in pattern of metastases.

AB - Background: Colorectal cancer is the second leading cause of cancer related mortality, with a majority of deaths resulting from metastases. Few in vivo models allow for the study of the complex process of metastasis. The purpose of this study was to determine the effects of epidermal growth factor receptor activation and TGFβ pathway attenuation in FET, a weakly tumorigenic human colon cancer cell line, in an orthotopic model. Methods and Results: Using FET, FETα, FETαDNRII, and FETDNRII cells were constructed. Tumors were orthotopically implanted onto the colons of BALB/c nude mice. After 7 wk, the mice were euthanized and organs extracted for examination. All cell lines demonstrated primary invasion. FETα was weakly metastatic compared with FETαDNRII and FETDNRII, which demonstrated metastases to the lung and liver, respectively. Conclusion: Epidermal growth factor receptor (EGFR) activation transforms a nontumorigenic cell line into a tumorigenic but not metastatic one. The tumorigenic line becomes metastatic with the attenuation of TGFβ signaling. Loss of EGFR activation in the TGFβ inhibited line results in a decreased metastatic burden, but importantly, changes the organotropic homing from lung to liver. Thus, these in vivo studies demonstrate that EGFR activation and TGFβ signaling pathways play a role in tumorigenicity and in pattern of metastases.

KW - Epidermal growth factor receptor

KW - colon cancer

KW - orthotopic model

KW - transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=70249114757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249114757&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2009.02.002

DO - 10.1016/j.jss.2009.02.002

M3 - Article

C2 - 19524264

AN - SCOPUS:70249114757

VL - 156

SP - 250

EP - 256

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -